Core Insights - The company reported third-quarter revenue of 367 million yuan, representing a year-on-year increase of 14.73% [1] - Net profit for the third quarter was 1.4872 million yuan, showing a significant year-on-year decline of 95.92% [1] - For the first three quarters, the company achieved revenue of 1.079 billion yuan, which is a year-on-year growth of 9.56% [1] - Net profit for the first three quarters was 42.5498 million yuan, reflecting a year-on-year decrease of 56.03% [1]

Revenue and Profitability - Revenue for Q3 2025 reached ¥367,205,252.81, an increase of 14.73% compared to the same period last year[5] - Net profit attributable to shareholders decreased by 95.92% to ¥1,487,200.83, while the net profit after deducting non-recurring gains and losses fell by 98.79% to ¥453,149.64[5] - Total operating revenue for the current period reached ¥1,078,874,052.86, an increase of 9.57% compared to ¥984,704,973.19 in the previous period[26] - Net profit for the current period was ¥42,403,252.01, a decrease of 56.14% from ¥96,790,316.11 in the previous period[27] - Basic earnings per share for the current period were ¥0.1596, down from ¥0.3631 in the previous period[28] Assets and Liabilities - Total assets as of September 30, 2025, amounted to ¥1,172,132,210.48, reflecting a growth of 6.23% from the end of the previous year[5] - Total assets increased to ¥1,172,132,210.48, compared to ¥1,103,346,118.01 in the previous period, reflecting a growth of 6.26%[24] - Total liabilities rose to ¥350,698,567.24, an increase of 25.14% from ¥280,009,676.12 in the previous period[24] - The company’s intangible assets increased by 92.14% to ¥291,065,108.53, reflecting ongoing development projects[9] - Deferred income tax assets increased to ¥91,267,889.99 from ¥76,855,644.74, marking a rise of 18.67%[24] Cash Flow - The company reported a 29.60% decline in net cash flow from operating activities, totaling ¥39,902,804.53 for the year-to-date[13] - Operating cash inflow for the current period was CNY 928,187,653.55, a slight increase from CNY 922,951,805.76 in the previous period[29] - Net cash outflow from operating activities was CNY 39,902,804.53, down from CNY 56,678,574.83 in the previous period[30] - Cash inflow from investment activities totaled CNY 238,666,204.95, compared to CNY 149,815,082.81 in the previous period[30] - Cash inflow from financing activities was CNY 30,014,544.16, with a net cash outflow of CNY 26,491,701.20, compared to a net outflow of CNY 49,781,796.36 in the previous period[30] Shareholder Information - Total number of common shareholders at the end of the reporting period is 17,452[15] - The largest shareholder, Chen Qinfang, holds 35.02% of shares, totaling 93,338,604 shares, with 14,644,000 shares pledged[15] - The company plans to repurchase shares using its own funds, with a total repurchase amount between RMB 30 million and RMB 50 million, at a price not exceeding RMB 23 per share[18] - As of September 30, 2025, the company has repurchased a total of 2,249,700 shares, representing 0.84% of the total share capital[20] Operating Costs and Expenses - Total operating costs amounted to ¥1,031,137,681.82, up 21.06% from ¥852,236,672.12 in the prior period[26] - The company’s financial expenses surged by 205.99% to ¥398,255.73, primarily due to reduced foreign exchange gains[12] - Research and development expenses for the current period were ¥40,483,039.47, down 17.16% from ¥48,895,920.66 in the previous period[27] - Cash paid for purchasing goods and services was CNY 622,079,280.28, an increase from CNY 583,529,139.50 in the previous period[30] - Cash paid to employees decreased to CNY 144,728,270.05 from CNY 171,317,281.65 in the previous period[30] Accounts Receivable and Payable - The company’s accounts payable rose by 57.66% to ¥200,334,768.73, driven by increased game distribution and publishing costs[9] - The company reported a significant increase in accounts payable, which rose to ¥200,334,768.73 from ¥127,066,568.53, representing a growth of 57.59%[24] - Accounts receivable decreased from RMB 241,718,639.65 to RMB 236,124,451.25 during the reporting period[21] - Prepayments decreased from RMB 124,671,876.03 to RMB 80,890,476.44[21] Other Information - The company has not disclosed any significant new product developments or market expansions in the current reporting period[18] - There are no reported changes in the top 10 shareholders due to share lending or borrowing activities[16]

Core Points - The gaming sector experienced a decline of 1.29% on October 16, with Mingchen Health leading the drop [1] - The Shanghai Composite Index closed at 3916.23, up 0.1%, while the Shenzhen Component Index closed at 13086.41, down 0.25% [1] Stock Performance - The table shows various gaming stocks with their closing prices, percentage changes, trading volumes, and transaction amounts, indicating mixed performance among individual stocks [1] - Notable declines include: - 37 Interactive Entertainment down 1.33% [1] - Glacier Network down 1.38% [1] - Yaoji Technology down 1.47% [1] - Conversely, ST Dazheng and ST Kaiwen showed slight increases of 0.99% and 0.26% respectively [1] Capital Flow - The gaming sector saw a net outflow of 833 million yuan from major funds, while retail investors contributed a net inflow of 628 million yuan [3] - Speculative funds recorded a net inflow of 205 million yuan [3]

New Stock Issuance - New stock issuance includes 泰凯英 (code: 920020) at an issuance price of 7.50 and 超颖电子 (code: 732175) at 17.08[1] Equity Market Alerts - 上纬新材 (code: 688585) is undergoing a tender offer from September 29, 2025, to October 28, 2025[1] - 科思科技 (code: 688788) and 博瑞医药 (code: 688166) have recent announcements dated September 26, 2025, and October 10, 2025, respectively[1] - 南新制药 (code: 688189) reported severe abnormal fluctuations on October 10, 2025[1] Trading Alerts - A total of 50 stocks have trading alerts with the latest announcements on October 15, 2025, including 国光连锁 (code: 605188) and 中持股份 (code: 603903)[1] - The lowest trading alert price recorded is 1,116 for 赛恩斯 (code: 688480)[1]

Core Viewpoint - Mingchen Health has seen a stock price increase of 5.41%, reaching 18.51 CNY per share, with a trading volume of 214 million CNY and a turnover rate of 4.52%, resulting in a total market capitalization of 4.933 billion CNY [1] Group 1: Company Overview - Mingchen Health Products Co., Ltd. is located in the Lian Nan Industrial Zone, Chenghai District, Shantou City, Guangdong Province, and was established on December 14, 1994, with its listing date on December 18, 2017 [1] - The company's main business involves the research, development, production, and sales of health care products, including shampoos, conditioners, shower gels, gel water, and skincare products [1] - The revenue composition of the main business is as follows: 76.84% from online games, 23.09% from daily chemical products, and 0.07% from other sources [1] Group 2: Fund Holdings - According to data from the top ten holdings of funds, one fund under Jiashi Fund has a significant position in Mingchen Health [2] - Jiashi Runze Quantitative Regular Mixed Fund (005167) held 15,000 shares in the second quarter, with no change in the number of shares held compared to the previous period, accounting for 0.84% of the fund's net value, ranking as the seventh largest holding [2] - The estimated floating profit for today is approximately 14,300 CNY [2] Group 3: Fund Manager Information - The fund manager of Jiashi Runze Quantitative Regular Mixed Fund (005167) is Lai Lihui [3] - As of the report date, Lai Lihui has a cumulative tenure of 4 years and 363 days, with the total asset size of the fund being 3.499 billion CNY [3] - The best fund return during Lai's tenure is 30.87%, while the worst return is 0.16% [3]

Group 1 - The stock of Mingchen Health Products Co., Ltd. (stock code: 002919) experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days (October 10, 2025, October 13, 2025, and October 14, 2025) [2] - The company's board confirmed that there were no significant undisclosed matters that could have impacted the stock price, and the company's recent operational conditions remained normal without major changes in the internal and external business environment [3][4] - The company has established a wholly-owned subsidiary, Fujian Xingxuan Shikong Network Technology Co., Ltd., with an investment of RMB 10 million, and the subsidiary has completed its business registration [6]

Core Viewpoint - Mingchen Health announced the establishment of a wholly-owned subsidiary, Fujian Xingxuan Shikong Network Technology Co., Ltd., with an investment of 10 million RMB, which has completed its business registration [2] Group 1 - The fourth meeting of the fourth board of directors is scheduled for August 28, 2025, to review the proposal for setting up the subsidiary [2] - The subsidiary has received its business license from the Market Supervision Administration of Fengze District, Quanzhou City [2]

Core Viewpoint - The company announced that its stock price has experienced an abnormal fluctuation, with a cumulative closing price increase of over 20% over three consecutive trading days from October 10 to October 14, 2025 [1] Summary by Relevant Sections - Stock Price Movement - The company's stock price has shown a significant increase, with a cumulative rise exceeding 20% over three trading days [1] - Company Disclosure - The company confirmed that there are no corrections or supplements needed for previously disclosed information [1] - The company has not identified any recent media reports that could have significantly impacted its stock price with undisclosed major information [1]

Core Viewpoint - The stock price of Mingchen Health has experienced an abnormal fluctuation, with a cumulative increase of over 20% in closing prices from October 10 to October 14, 2025 [1] Company Information - The company has confirmed that there are no corrections or supplements needed for previously disclosed information [1] - There have been no significant media reports affecting the company's stock price recently [1] - The company's operational status remains normal, and there have been no major changes in the internal or external operating environment [1] - The controlling shareholder and actual controller did not buy or sell company stocks during the period of abnormal fluctuation [1] - There are no undisclosed significant matters that need to be reported [1] Investor Guidance - The company advises investors to pay attention to information released by officially designated media and to invest rationally while being aware of risks [1]

证券代码：002919 证券简称：名臣健康 公告编号：2025-036 名臣健康用品股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 名臣健康用品股份有限公司（以下简称"公司"）（证券代码：002919，证 券简称：名臣健康）股票交易价格连续 3 个交易日内（2025 年 10 月 10 日、2025 年 10 月 13 日、2025 年 10 月 14 日）收盘价格涨幅偏离值累计超过 20%，根据《深 圳证券交易所交易规则》的有关规定，属于股票交易异常波动的情况。 二、对重要问题关注、核实情况的说明 针对公司股票交易异常波动，公司董事会对公司、控股股东及实际控制人就 相关事项进行了核实，现就有关情况说明如下： 1、公司前期披露的信息不存在需要更正、补充之处； 2、公司未发现近期有媒体报道了可能或已经对公司股票交易价格产生较大 影响的未公开重大信息； 3、公司近期经营情况正常，内外部经营环境未发生重大变化； 4、经核查，公司控股股东、实际控制人在股票异常波动期间不存在买卖公 司股票的情形；公司、控股股东、实际控制人不存在关于公 ...